Parkinson's pill trial halted early after testing in small group
NCT ID NCT06822517
Summary
This early-stage study tested whether an oral medication called VENT-02 is safe for people with mild to moderate Parkinson's disease. About 30 participants took either the drug or a placebo pill twice daily for 28 days while researchers monitored for side effects and measured inflammation markers. The trial was terminated early and did not assess whether the drug improves Parkinson's symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigative Site
Fountain Valley, California, 92708, United States
-
Investigative Site
San Jose, California, 95124, United States
-
Investigative Site
West Hills, California, 91307, United States
-
Investigative Site
Englewood, Colorado, 80113, United States
-
Investigative Site
Aventura, Florida, 33180, United States
-
Investigative Site
Boca Raton, Florida, 33486, United States
-
Investigative Site
Coral Gables, Florida, 33134, United States
-
Investigative Site
Coral Springs, Florida, 33067, United States
-
Investigative Site
Cutler Bay, Florida, 33189, United States
-
Investigative Site
Daytona Beach, Florida, 32117, United States
-
Investigative Site
Doral, Florida, 33178, United States
-
Investigative Site
Jacksonville, Florida, 32256, United States
-
Investigative Site
Maitland, Florida, 32751, United States
-
Investigative Site
Miami, Florida, 33135, United States
-
Investigative Site
Miami, Florida, 33165, United States
-
Investigative Site
Winter Park, Florida, 32789, United States
-
Investigative Site
Scarborough, Maine, 04074, United States
-
Investigative Site
Farmington Hills, Michigan, 48334, United States
-
Investigative Site
Abington, Pennsylvania, 19001, United States
-
Investigative Site
Memphis, Tennessee, 38157, United States
-
Investigative Site
Cypress, Texas, 77429, United States
-
Investigative Site
Round Rock, Texas, 78681, United States
-
Investigative Site
Spokane, Washington, 99202, United States
Conditions
Explore the condition pages connected to this study.